SkyePharma PLC Rating Reiterated by N+1 Singer (SKP)
SkyePharma PLC (LON:SKP)‘s stock had its “corporate” rating restated by analysts at N+1 Singer in a research report issued to clients and investors on Monday, Analyst Ratings Net reports.
Shares of SkyePharma PLC (LON:SKP) traded down 0.22% during mid-day trading on Monday, hitting GBX 112.00. The stock had a trading volume of 10,142 shares. SkyePharma PLC has a 52 week low of GBX 39.00 and a 52 week high of GBX 123.00. The stock has a 50-day moving average of GBX 114.5 and a 200-day moving average of GBX 90.17. The company’s market cap is £51.6 million.
SkyePharma PLC is a speciality drug delivery company developing oral and inhalation products. The principal activities of the Company included the research and development, manufacture and sale of prescription pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.